HRTX
Companies
NASDAQ
Heron Therapeutics Inc.
Health Care
$1.95
+$0.42 (+27.45%)
Price Chart
Overview
About HRTX
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
Market Cap
$542.4M
Volume
3.7M
Avg. Volume
3.6M
P/E Ratio
178
Dividend Yield
0.00%
Employees
204.0
Company Information
Latest News for HRTX
Risk & Correlation Analysis
Market Correlation
1.22
Moderate Correlation
Volatility
High (0.98)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Low Sensitivity
GDP Growth
High Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, HRTX shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$542.4M
Volume3.7M
P/E Ratio178.00
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 6, 2025Related Securities
Pricing info last updated June 17, 2025 (after market close)Other info last updated April 2, 2025